Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indian Guidelines on Nebulization Therapy.

The Indian journal of tuberculosis·2022
Same author

Epidemiological Profile of Tobacco Users at Tobacco Cessation Centre: An Indian Experience.

The Indian journal of chest diseases & allied sciences·2018
Same author

Caregiver's burden in pulmonary arterial hypertension: a clinical review.

Journal of exercise rehabilitation·2016
Same author

Role of oxidative stress & transient receptor potential in chronic obstructive pulmonary disease.

The Indian journal of medical research·2015
Same author

Consensus & Evidence-based INOSA Guidelines 2014 (First edition).

The Indian journal of chest diseases & allied sciences·2015
Same author

Consensus and evidence-based Indian initiative on obstructive sleep apnea guidelines 2014 (first edition).

Lung India : official organ of Indian Chest Society·2015

Related Experiment Video

Updated: May 12, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Chronic obstructive pulmonary disease.

V K Vijayan1

  • 1Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India. vijayanvk@hotmail.com

The Indian Journal of Medical Research
|April 9, 2013
PubMed
Summary
This summary is machine-generated.

Chronic Obstructive Pulmonary Disease (COPD) affects 9-10% of adults over 40 globally. This multifactorial respiratory disease requires comprehensive assessment and management, including pharmacological and non-pharmacological treatments.

More Related Videos

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 12, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
04:53

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Global prevalence of physiologically defined Chronic Obstructive Pulmonary Disease (COPD) in adults over 40 is 9-10%.
  • Chronic bronchitis prevalence in Indian adults over 35 is 3.49%.
  • COPD development is multifactorial, influenced by genetic and environmental risk factors.

Purpose of the Study:

  • To outline the multifactorial nature of COPD development.
  • To describe the pathological changes and proposed pathogenesis of COPD.
  • To detail the assessment, management, and prevention strategies for COPD.

Main Methods:

  • Physiological definition of airflow limitation using postbronchodilator FEV1/FVC ratio <0.70.
  • Characterization of COPD by accelerated decline in FEV1.
  • Review of associated comorbidities, including cardiovascular, metabolic, bone, and neurological disorders.

Main Results:

  • COPD is characterized by airflow limitation and accelerated FEV1 decline.
  • Numerous comorbidities are associated with COPD, impacting overall health.
  • Comprehensive assessment is crucial for guiding COPD therapy.

Conclusions:

  • COPD management involves pharmacological treatments like bronchodilators and corticosteroids.
  • Non-pharmacological interventions include smoking cessation, pulmonary rehabilitation, and nutritional support.
  • Vaccinations against influenza and pneumococcus are recommended for COPD patients.